SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline
Li, SY; Vandvik, PO; Lytvyn, L; Guyatt, GH; Palmer, SC; Rodriguez-Gutierrez, R; Foroutan, F; Agoritsas, T; Siemieniuk, RAC; Walsh, M; Frere, L; Tunnicliffe, DJ; Nagler, EV; Manja, V; Asvold, BO; Jha, V; Vermandere, M; Gariani, K; Zhao, Q; Ren, Y; Cartwright, EJ; Gee, P; Wickes, A; Ferns, L; Wright, R; Li, L; Hao, QK; Mustafa, RA
Hao, QK; Mustafa, RA (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.; Hao, QK (corresponding author), Sichuan Univ, West China Hosp, Ctr Gerontol & Geriatr, Natl Clin Res Ctr Geriatr, Chengdu, Peoples R China.; Mustafa, RA (corresponding author), Univ Kansas, Dept Internal Med, Div Nephrol & Hypertens, Kansas City, KS 64110 USA.
BMJ-BRITISH MEDICAL JOURNAL, 2021; 373 ():
